In vitro activities of enoxacin and 17 other antimicrobial agents against multiply resistant, gram-negative bacteria
- 1 July 1984
- journal article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 26 (1) , 97-100
- https://doi.org/10.1128/aac.26.1.97
Abstract
Enoxacin (CI-919) was evaluated for activity against 120 multiply resistant clinical isolates of the family Enterobacteriaceae and Pseudomonas aeruginosa. The MIC of enoxacin for 95% of the strains tested was less than or equal to 2 micrograms/ml. Approximately 90% of the isolates were susceptible to enoxacin, norfloxacin, ceftazidime, moxalactam, cefotaxime, cefoperazone, and amikacin. Marked resistance to the other seven antimicrobial agents tested was observed.Keywords
This publication has 7 references indexed in Scilit:
- In vitro activity of enoxacin, a quinolone carboxylic acid, compared with those of norfloxacin, new beta-lactams, aminoglycosides, and trimethoprimAntimicrobial Agents and Chemotherapy, 1983
- In vitro and in vivo antibacterial activity of AT-2266Antimicrobial Agents and Chemotherapy, 1983
- Pharmacokinetics of AT-2266 Administered Orally to Mice, Rats, Dogs, and MonkeysAntimicrobial Agents and Chemotherapy, 1983
- Activity of AT-2266 compared with those of norfloxacin, pipemidic acid, nalidixic acid, and gentamicin against various experimental infections in miceAntimicrobial Agents and Chemotherapy, 1983
- In vitro activity of CI-919 (AT-2266), an oral antipseudomonal compoundAntimicrobial Agents and Chemotherapy, 1983
- In vitro antibacterial properties of AT-2266, a new pyridonecarboxylic acidAntimicrobial Agents and Chemotherapy, 1983
- Tentative interpretive standards for disk diffusion susceptibility testing with norfloxacin (MK-0366, AM-715)Antimicrobial Agents and Chemotherapy, 1983